{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:27:32Z","timestamp":1787509652952,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T00:00:00Z","timestamp":1671926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T00:00:00Z","timestamp":1671926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Soluble tumor necrosis factor receptor (sTNFR)1, sTNFR2, and plasma kidney injury molecule-1 (KIM-1) are associated with kidney events in patients with and without diabetes. However, their associations with clinical outcomes when obtained pre-operatively have not been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The TRIBE-AKI cohort study is a prospective, multicenter, cohort study of high-risk adults undergoing cardiac surgery. We assessed the associations between pre-operative concentrations of plasma sTNFR1, sTNFR2, and KIM-1 and post-operative long-term outcomes including mortality, cardiovascular events, and chronic kidney disease (CKD) incidence or progression after discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1378 participants included in the analysis with a median follow-up period of 6.7 (IQR 4.0\u20137.9) years, 434 (31%) patients died, 256 (19%) experienced cardiovascular events and out of 837 with available long-term kidney function data, 30% developed CKD. After adjustment for clinical covariates, each log increase in biomarker concentration was independently associated with mortality with 95% CI adjusted hazard ratios (aHRs) of 3.0 (2.3\u20134.0), 2.3 (1.8\u20132.9), and 2.0 (1.6\u20132.4) for sTNFR1, sTNFR2, and KIM-1, respectively. For cardiovascular events, the 95% CI aHRs were 2.1 (1.5\u20133.1), 1.9 (1.4\u20132.6) and 1.6 (1.2\u20132.1) for sTNFR1, sTNFR2 and KIM-1, respectively. For CKD events, the aHRs were 2.2 (1.5\u20133.1) for sTNFR1, 1.9 (1.3\u20132.7) for sTNFR2, and 1.7 (1.3\u20132.3) for KIM-1. Despite the associations, each of the biomarkers alone or in combination failed to result in robust discrimination on an absolute basis or compared to a clinical model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>sTNFR1, sTNFR2, and KIM-1 were independently associated with longitudinal outcomes after discharge from a cardiac surgery hospitalization including death, cardiovascular, and CKD events when obtained pre-operatively in high-risk individuals. Pre-operative plasma biomarkers could serve to assist during the evaluation of patients in whom cardiac surgery is planned.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13019-022-02066-4","type":"journal-article","created":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T06:02:42Z","timestamp":1671948162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pre-operative kidney biomarkers and risks for death, cardiovascular and chronic kidney disease events after cardiac surgery: the TRIBE-AKI study"],"prefix":"10.1186","volume":"17","author":[{"given":"George","family":"Vasquez-Rios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis G.","family":"Moledina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry G.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Thiessen-Philbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay L.","family":"Koyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Coca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the TRIBE-AKI Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,25]]},"reference":[{"issue":"21","key":"2066_CR1","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2014.4952","volume":"311","author":"AX Garg","year":"2014","unstructured":"Garg AX, Devereaux PJ, Yusuf S, et al. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. JAMA. 2014;311(21):2191\u20138.","journal-title":"JAMA"},{"issue":"18","key":"2066_CR2","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1161\/CIRCULATIONAHA.108.800011","volume":"119","author":"CE Hobson","year":"2009","unstructured":"Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119(18):2444\u201353.","journal-title":"Circulation"},{"issue":"3","key":"2066_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1001\/archinternmed.2010.514","volume":"171","author":"A Ishani","year":"2011","unstructured":"Ishani A, Nelson D, Clothier B, et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med. 2011;171(3):226\u201333.","journal-title":"Arch Intern Med"},{"issue":"5","key":"2066_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/heart.88.5.488","volume":"88","author":"PJ Bradshaw","year":"2002","unstructured":"Bradshaw PJ, Jamrozik K, Le M, Gilfillan I, Thompson PL. Mortality and recurrent cardiac events after coronary artery bypass graft: long term outcomes in a population study. Heart. 2002;88(5):488\u201394.","journal-title":"Heart"},{"issue":"2","key":"2066_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/0971-9784.154462","volume":"18","author":"LS Hansen","year":"2015","unstructured":"Hansen LS, Hjortdal VE, Andreasen JJ, Mortensen PE, Jakobsen CJ. 30-day mortality after coronary artery bypass grafting and valve surgery has greatly improved over the last decade, but the 1-year mortality remains constant. Ann Card Anaesth. 2015;18(2):138\u201342.","journal-title":"Ann Card Anaesth"},{"issue":"1","key":"2066_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s13054-020-03179-9","volume":"24","author":"PY Tseng","year":"2020","unstructured":"Tseng PY, Chen YT, Wang CH, et al. Prediction of the development of acute kidney injury following cardiac surgery by machine learning. Crit Care. 2020;24(1):478.","journal-title":"Crit Care"},{"issue":"1","key":"2066_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.athoracsur.2011.09.010","volume":"93","author":"SC Huen","year":"2012","unstructured":"Huen SC, Parikh CR. Predicting acute kidney injury after cardiac surgery: a systematic review. Ann Thorac Surg. 2012;93(1):337\u201347.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"2066_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.108.786913","volume":"119","author":"K Karkouti","year":"2009","unstructured":"Karkouti K, Wijeysundera DN, Yau TM, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119(4):495\u2013502.","journal-title":"Circulation"},{"issue":"2","key":"2066_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccc.2016.12.008","volume":"33","author":"C Hobson","year":"2017","unstructured":"Hobson C, Ruchi R, Bihorac A. Perioperative acute kidney injury: risk factors and predictive strategies. Crit Care Clin. 2017;33(2):379\u201396.","journal-title":"Crit Care Clin"},{"issue":"6","key":"2066_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/HCO.0b013e32831217ed","volume":"23","author":"JY Dupuis","year":"2008","unstructured":"Dupuis JY. Predicting outcomes in cardiac surgery: risk stratification matters? Curr Opin Cardiol. 2008;23(6):560\u20137.","journal-title":"Curr Opin Cardiol"},{"key":"2066_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-020518-114605","volume":"81","author":"WR Zhang","year":"2019","unstructured":"Zhang WR, Parikh CR. Biomarkers of acute and chronic kidney disease. Annu Rev Physiol. 2019;81:309\u201333.","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"2066_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1681\/ASN.2011060628","volume":"23","author":"T Gohda","year":"2012","unstructured":"Gohda T, Niewczas MA, Ficociello LH, et al. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol. 2012;23(3):516\u201324.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2066_CR13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2215\/CJN.12051115","volume":"11","author":"GN Nadkarni","year":"2016","unstructured":"Nadkarni GN, Rao V, Ismail-Beigi F, et al. Association of urinary biomarkers of inflammation, injury, and fibrosis with renal function decline: the ACCORD trial. Clin J Am Soc Nephrol. 2016;11(8):1343\u201352.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"2066_CR14","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.2215\/CJN.02590315","volume":"10","author":"MC Foster","year":"2015","unstructured":"Foster MC, Coresh J, Bonventre JV, et al. Urinary biomarkers and risk of ESRD in the atherosclerosis risk in communities study. Clin J Am Soc Nephrol. 2015;10(11):1956\u201363.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2066_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.kint.2016.09.003","volume":"91","author":"CY Hsu","year":"2017","unstructured":"Hsu CY, Xie D, Waikar SS, et al. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. Kidney Int. 2017;91(1):196\u2013203.","journal-title":"Kidney Int"},{"issue":"9","key":"2066_CR16","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1681\/ASN.2016101101","volume":"28","author":"SG Coca","year":"2017","unstructured":"Coca SG, Nadkarni GN, Huang Y, et al. Plasma biomarkers and kidney function decline in early and established diabetic kidney disease. J Am Soc Nephrol. 2017;28(9):2786\u201393.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2066_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1681\/ASN.2020040487","volume":"32","author":"SJ Schrauben","year":"2021","unstructured":"Schrauben SJ, Shou H, Zhang X, et al. Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the chronic renal insufficiency cohort (CRIC) study. J Am Soc Nephrol. 2021;32(1):115\u201326.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2066_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00125-019-05052-z","volume":"63","author":"M Colombo","year":"2020","unstructured":"Colombo M, McGurnaghan SJ, Bell S, et al. Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus. Diabetologia. 2020;63(3):636\u201347.","journal-title":"Diabetologia"},{"issue":"3","key":"2066_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2011060627","volume":"23","author":"MA Niewczas","year":"2012","unstructured":"Niewczas MA, Gohda T, Skupien J, et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012;23(3):507\u201315.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2066_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2337\/dc14-2330","volume":"38","author":"NM Panduru","year":"2015","unstructured":"Panduru NM, Sandholm N, Forsblom C, et al. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes. Diabetes Care. 2015;38(6):1130\u20137.","journal-title":"Diabetes Care"},{"key":"2066_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","volume":"10","author":"P Vassalli","year":"1992","unstructured":"Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10:411\u201352.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"2066_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/sj.ki.5002132","volume":"71","author":"X Dong","year":"2007","unstructured":"Dong X, Swaminathan S, Bachman LA, Croatt AJ, Nath KA, Griffin MD. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 2007;71(7):619\u201328.","journal-title":"Kidney Int"},{"issue":"6618","key":"2066_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"RA Black","year":"1997","unstructured":"Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385(6618):729\u201333.","journal-title":"Nature"},{"issue":"3","key":"2066_CR24","doi-asserted-by":"crossref","first-page":"R577","DOI":"10.1152\/ajpcell.1998.274.3.C577","volume":"274","author":"DR Meldrum","year":"1998","unstructured":"Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998;274(3):R577-595.","journal-title":"Am J Physiol"},{"issue":"2","key":"2066_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ki.2014.285","volume":"87","author":"RS Al-Lamki","year":"2015","unstructured":"Al-Lamki RS, Mayadas TN. TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int. 2015;87(2):281\u201396.","journal-title":"Kidney Int"},{"issue":"12","key":"2066_CR26","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1096\/fj.05-3841com","volume":"19","author":"RS Al-Lamki","year":"2005","unstructured":"Al-Lamki RS, Wang J, Vandenabeele P, et al. TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J. 2005;19(12):1637\u201345.","journal-title":"FASEB J"},{"issue":"1\u20132","key":"2066_CR27","first-page":"8","volume":"47","author":"M Grell","year":"1995","unstructured":"Grell M. Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J Inflamm. 1995;47(1\u20132):8\u201317.","journal-title":"J Inflamm"},{"key":"2066_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/00365510802145059","volume":"241","author":"JV Bonventre","year":"2008","unstructured":"Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl. 2008;241:78\u201383.","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"2066_CR29","first-page":"293","volume":"125","author":"JV Bonventre","year":"2014","unstructured":"Bonventre JV. Kidney injury molecule-1: a translational journey. Trans Am Clin Climatol Assoc. 2014;125:293\u20139 (discussion 299).","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"9","key":"2066_CR30","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/ki.2012.11","volume":"81","author":"T Ichimura","year":"2012","unstructured":"Ichimura T, Brooks CR, Bonventre JV. Kim-1\/Tim-1 and immune cells: shifting sands. Kidney Int. 2012;81(9):809\u201311.","journal-title":"Kidney Int"},{"issue":"4","key":"2066_CR31","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/jgs.15268","volume":"66","author":"S Salimi","year":"2018","unstructured":"Salimi S, Shardell MD, Seliger SL, Bandinelli S, Guralnik JM, Ferrucci L. Inflammation and trajectory of renal function in community-dwelling older adults. J Am Geriatr Soc. 2018;66(4):804\u201311.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"2066_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3195","volume":"35","author":"X Ye","year":"2019","unstructured":"Ye X, Luo T, Wang K, et al. Circulating TNF receptors 1 and 2 predict progression of diabetic kidney disease: a meta-analysis. Diabetes Metab Res Rev. 2019;35(8): e3195.","journal-title":"Diabetes Metab Res Rev"},{"issue":"7","key":"2066_CR33","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00125-021-05444-0","volume":"64","author":"L Chan","year":"2021","unstructured":"Chan L, Nadkarni GN, Fleming F, et al. Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease. Diabetologia. 2021;64(7):1504\u201315.","journal-title":"Diabetologia"},{"key":"2066_CR34","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00125-021-05512-5","volume":"64","author":"T Sen","year":"2021","unstructured":"Sen T, Li J, Neuen BL, et al. Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial. Diabetologia. 2021;64:2147\u201358.","journal-title":"Diabetologia"},{"issue":"9","key":"2066_CR35","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1681\/ASN.2010121302","volume":"22","author":"CR Parikh","year":"2011","unstructured":"Parikh CR, Coca SG, Thiessen-Philbrook H, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol. 2011;22(9):1748\u201357.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2066_CR36","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1681\/ASN.2010111163","volume":"22","author":"CR Parikh","year":"2011","unstructured":"Parikh CR, Devarajan P, Zappitelli M, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol. 2011;22(9):1737\u201347.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2066_CR37","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1681\/ASN.2013070742","volume":"25","author":"SG Coca","year":"2014","unstructured":"Coca SG, Garg AX, Thiessen-Philbrook H, et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol. 2014;25(5):1063\u201371.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2066_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1681\/ASN.2011090907","volume":"23","author":"JL Koyner","year":"2012","unstructured":"Koyner JL, Garg AX, Coca SG, et al. Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol. 2012;23(5):905\u201314.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2066_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161098","volume":"11","author":"SG Coca","year":"2016","unstructured":"Coca SG, Nadkarni GN, Garg AX, et al. First post-operative urinary kidney injury biomarkers and association with the duration of AKI in the TRIBE-AKI cohort. PLoS ONE. 2016;11(8): e0161098.","journal-title":"PLoS ONE"},{"issue":"4","key":"2066_CR40","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1053\/j.ajkd.2010.02.337","volume":"55","author":"AS Levey","year":"2010","unstructured":"Levey AS, Stevens LA. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010;55(4):622\u20137.","journal-title":"Am J Kidney Dis"},{"key":"2066_CR41","doi-asserted-by":"publisher","first-page":"17917","DOI":"10.1038\/srep17917","volume":"5","author":"J Xiong","year":"2015","unstructured":"Xiong J, Tang X, Hu Z, Nie L, Wang Y, Zhao J. The RIFLE versus AKIN classification for incidence and mortality of acute kidney injury in critical ill patients: a meta-analysis. Sci Rep. 2015;5:17917.","journal-title":"Sci Rep"},{"key":"2066_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2369-11-22","volume":"11","author":"AS Go","year":"2010","unstructured":"Go AS, Parikh CR, Ikizler TA, et al. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010;11:22.","journal-title":"BMC Nephrol"},{"issue":"4","key":"2066_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2682","volume":"3","author":"PK Bhatraju","year":"2020","unstructured":"Bhatraju PK, Zelnick LR, Chinchilli VM, et al. Association between early recovery of kidney function after acute kidney injury and long-term clinical outcomes. JAMA Netw Open. 2020;3(4): e202682.","journal-title":"JAMA Netw Open"},{"key":"2066_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2017.05.021","volume":"263","author":"M Park","year":"2017","unstructured":"Park M, Maristany D, Huang D, Shlipak MG, Whooley M. Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: data from the Heart and Soul Study. Atherosclerosis. 2017;263:68\u201373.","journal-title":"Atherosclerosis"},{"issue":"12","key":"2066_CR45","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1681\/ASN.2017010055","volume":"28","author":"CR Parikh","year":"2017","unstructured":"Parikh CR, Puthumana J, Shlipak MG, et al. Relationship of kidney injury biomarkers with long-term cardiovascular outcomes after cardiac surgery. J Am Soc Nephrol. 2017;28(12):3699\u2013707.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2066_CR46","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1681\/ASN.2013070713","volume":"25","author":"MJ Sarnak","year":"2014","unstructured":"Sarnak MJ, Katz R, Newman A, et al. Association of urinary injury biomarkers with mortality and cardiovascular events. J Am Soc Nephrol. 2014;25(7):1545\u201353.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2066_CR47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/ndt\/gfy382","volume":"35","author":"CA Schulz","year":"2020","unstructured":"Schulz CA, Engstrom G, Nilsson J, et al. Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years. Nephrol Dial Transplant. 2020;35(2):265\u201373.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"2066_CR48","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1681\/ASN.2013070758","volume":"25","author":"VS Sabbisetti","year":"2014","unstructured":"Sabbisetti VS, Waikar SS, Antoine DJ, et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol. 2014;25(10):2177\u201386.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2066_CR49","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1681\/ASN.2018070719","volume":"29","author":"PK Bhatraju","year":"2018","unstructured":"Bhatraju PK, Zelnick LR, Shlipak M, Katz R, Kestenbaum B. Association of soluble TNFR-1 concentrations with long-term decline in kidney function: the multi-ethnic study of atherosclerosis. J Am Soc Nephrol. 2018;29(11):2713\u201321.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2066_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10741-010-9180-8","volume":"16","author":"P Kleinbongard","year":"2011","unstructured":"Kleinbongard P, Schulz R, Heusch G. TNFalpha in myocardial ischemia\/reperfusion, remodeling and heart failure. Heart Fail Rev. 2011;16(1):49\u201369.","journal-title":"Heart Fail Rev"},{"issue":"6","key":"2066_CR51","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.yjmcc.2008.09.119","volume":"45","author":"R Schulz","year":"2008","unstructured":"Schulz R. TNFalpha in myocardial ischemia\/reperfusion: damage versus protection. J Mol Cell Cardiol. 2008;45(6):712\u20134.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"2066_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000967","volume":"18","author":"K Miao","year":"2020","unstructured":"Miao K, Zhou L, Ba H, et al. Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2. PLoS Biol. 2020;18(12): e3000967.","journal-title":"PLoS Biol"},{"issue":"15","key":"2066_CR53","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1161\/01.CIR.0000124227.00670.AB","volume":"109","author":"Y Higuchi","year":"2004","unstructured":"Higuchi Y, McTiernan CF, Frye CB, McGowan BS, Chan TO, Feldman AM. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy. Circulation. 2004;109(15):1892\u20137.","journal-title":"Circulation"},{"issue":"10","key":"2066_CR54","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1161\/CIRCULATIONAHA.108.802918","volume":"119","author":"T Hamid","year":"2009","unstructured":"Hamid T, Gu Y, Ortines RV, et al. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation. 2009;119(10):1386\u201397.","journal-title":"Circulation"},{"key":"2066_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.atherosclerosis.2018.03.020","volume":"272","author":"AC Carlsson","year":"2018","unstructured":"Carlsson AC, Jansson JH, Soderberg S, Ruge T, Larsson A, Arnlov J. Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden. Atherosclerosis. 2018;272:41\u20136.","journal-title":"Atherosclerosis"},{"issue":"2","key":"2066_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055477","volume":"8","author":"L Nilsson","year":"2013","unstructured":"Nilsson L, Szymanowski A, Swahn E, Jonasson L. Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction. PLoS ONE. 2013;8(2): e55477.","journal-title":"PLoS ONE"},{"key":"2066_CR57","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008299","author":"AC Carlsson","year":"2018","unstructured":"Carlsson AC, Ruge T, Kjoller E, et al. 10-year associations between tumor necrosis factor receptors 1 and 2 and cardiovascular events in patients with stable coronary heart disease: a CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) trial substudy. J Am Heart Assoc. 2018. https:\/\/doi.org\/10.1161\/JAHA.117.008299.","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"2066_CR58","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006666","volume":"96","author":"E Bae","year":"2017","unstructured":"Bae E, Cha RH, Kim YC, et al. Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease. Medicine (Baltimore). 2017;96(19): e6666.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2066_CR59","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/MCC.0b013e32834008d3","volume":"16","author":"JV Bonventre","year":"2010","unstructured":"Bonventre JV, Yang L. Kidney injury molecule-1. Curr Opin Crit Care. 2010;16(6):556\u201361.","journal-title":"Curr Opin Crit Care"},{"issue":"7","key":"2066_CR60","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","volume":"273","author":"T Ichimura","year":"1998","unstructured":"Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273(7):4135\u201342.","journal-title":"J Biol Chem"},{"issue":"4","key":"2066_CR61","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.semnephrol.2014.06.006","volume":"34","author":"K Berger","year":"2014","unstructured":"Berger K, Moeller MJ. Mechanisms of epithelial repair and regeneration after acute kidney injury. Semin Nephrol. 2014;34(4):394\u2013403.","journal-title":"Semin Nephrol"},{"issue":"23","key":"2066_CR62","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1056\/NEJMra1916393","volume":"382","author":"M Legrand","year":"2020","unstructured":"Legrand M, Rossignol P. Cardiovascular consequences of acute kidney injury. N Engl J Med. 2020;382(23):2238\u201347.","journal-title":"N Engl J Med"},{"issue":"3","key":"2066_CR63","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.kint.2020.06.037","volume":"99","author":"S Menez","year":"2021","unstructured":"Menez S, Moledina DG, Garg AX, et al. Results from the TRIBE-AKI Study found associations between post-operative blood biomarkers and risk of chronic kidney disease after cardiac surgery. Kidney Int. 2021;99(3):716\u201324.","journal-title":"Kidney Int"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-02066-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-022-02066-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-02066-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T07:02:40Z","timestamp":1671951760000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-022-02066-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,25]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2066"],"URL":"https:\/\/doi.org\/10.1186\/s13019-022-02066-4","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,25]]},"assertion":[{"value":"20 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent prior to the participation in this study. The Ethics review board committee of Yale University School of Medicine, Duke University, and London Health Sciences Centre approved the current research study.\u00a0All participants provided written informed consent. The reporting of this study follows guidelines set out in the Strengthening the Reporting of Observational Studies in Epidemiology statement.\u00a0All methods were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors provided consent for publication of the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The research reported in this article was supported by the American Heart Association Clinical Development Award, as well as by the grant R01HL-085757 from the National Heart, Lung, and Blood Institute. C.R.P. is also supported by an NIH grant (K24DK090203). S.G.C., A.X.G., and C.R.P. are also members of the NIH-sponsored Assess, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Consortium (U01DK082185). S.G.C. M.G.S, and C.R.P. are members and are supported in part by the Chronic Kidney Disease Biomarker Consortium (1U01DK106962-01). DGM is supported by K23DK117065. JLK is supported by R21DK113420. The study was also supported by CTSA Grant Number UL1 RR024139 from the National Center for Research Resources (NCRR). This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC); Dr. Amit Garg is supported by the Dr. Adam Linton Chair in Kidney Health Analytics; no other relationships or activities that could appear to have influenced the submitted work. S.G.C. and C.R.P. are on the Advisory Board of RenalytixAI, and both own equity in the same. S.G.C. has served as a consultant for AKI therapeutics for Quark Biopharma and CHF Solutions. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and information compiled and provided by CIHI. However, the analyses, conclusions, opinions, and statements expressed herein are those of the authors, and not necessarily those of CIHI. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. All the other authors declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}